QUOTED. Jan. 17, 2018. Ariel Weinstein.
Executive Summary
Check out what OCON Medical CEO Ariel Weinstein had to say about his company's efforts to leverage its "intrauterine ball" hormone-free contraceptive platform for future pipeline projects.
"We're a small company and we see this as a nice breakthrough – there has never been an attempt to use the uterus to deliver drugs."– Ariel Weinstein, CEO, OCON Medical
> Find out more: Start-Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device
Click here for a free trial of Medtech Insight